Literature DB >> 29421541

Ion channel dysfunction in cerebellar ataxia.

David D Bushart1, Vikram G Shakkottai2.   

Abstract

Cerebellar ataxias constitute a heterogeneous group of disorders that result in impaired speech, uncoordinated limb movements, and impaired balance, often ultimately resulting in wheelchair confinement. Motor dysfunction in ataxia can be attributed to dysfunction and degeneration of neurons in the cerebellum and its associated pathways. Recent work has suggested the importance of cerebellar neuronal dysfunction resulting from mutations in specific ion-channels that regulate membrane excitability in the pathogenesis of cerebellar ataxia in humans. Importantly, even in ataxias not directly due to ion-channel mutations, transcriptional changes resulting in ion-channel dysfunction are tied to motor dysfunction and degeneration in models of disease. In this review, we describe the role that ion-channel dysfunction plays in a variety of cerebellar ataxias, and postulate that a potential therapeutic strategy that targets specific ion-channels exists for cerebellar ataxia.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Channel activator; Electrophysiology; Ion channel; Potassium channel; Purkinje neuron; Spinocerebellar ataxia

Mesh:

Substances:

Year:  2018        PMID: 29421541      PMCID: PMC6077100          DOI: 10.1016/j.neulet.2018.02.005

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  114 in total

1.  ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.

Authors:  Yung C Lam; Aaron B Bowman; Paymaan Jafar-Nejad; Janghoo Lim; Ronald Richman; John D Fryer; Eric D Hyun; Lisa A Duvick; Harry T Orr; Juan Botas; Huda Y Zoghbi
Journal:  Cell       Date:  2006-12-29       Impact factor: 41.582

2.  Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.

Authors:  Michael F Waters; Natali A Minassian; Giovanni Stevanin; Karla P Figueroa; John P A Bannister; Dagmar Nolte; Allan F Mock; Virgilio Gerald H Evidente; Dominic B Fee; Ulrich Müller; Alexandra Dürr; Alexis Brice; Diane M Papazian; Stefan M Pulst
Journal:  Nat Genet       Date:  2006-02-26       Impact factor: 38.330

3.  Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels.

Authors:  Jun-Yang Lou; Fernanda Laezza; Benjamin R Gerber; Maolei Xiao; Kathryn A Yamada; Hali Hartmann; Ann Marie Craig; Jeanne M Nerbonne; David M Ornitz
Journal:  J Physiol       Date:  2005-09-15       Impact factor: 5.182

4.  Do mutations in the murine ataxia gene TRPC3 cause cerebellar ataxia in humans?

Authors:  Brent L Fogel; Sonya M Hanson; Esther B E Becker
Journal:  Mov Disord       Date:  2014-12-05       Impact factor: 10.338

5.  Pharmacological characterization of a non-inactivating outward current observed in mouse cerebellar Purkinje neurones.

Authors:  Trevor Bushell; Catherine Clarke; Alistair Mathie; Brian Robertson
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

6.  Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.

Authors:  Melissa Ingram; Emily A L Wozniak; Christine Henzler; Lisa Duvick; Rendong Yang; Paul Bergmann; Robert Carson; Brennon O'Callaghan; Huda Y Zoghbi; Harry T Orr
Journal:  Neuron       Date:  2016-03-03       Impact factor: 17.173

7.  FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons.

Authors:  Vikram G Shakkottai; Maolei Xiao; Lin Xu; Michael Wong; Jeanne M Nerbonne; David M Ornitz; Kelvin A Yamada
Journal:  Neurobiol Dis       Date:  2008-10-01       Impact factor: 5.996

8.  Allele-dependent changes of olivocerebellar circuit properties in the absence of the voltage-gated potassium channels Kv3.1 and Kv3.3.

Authors:  Anne McMahon; Stephen C Fowler; Teresa M Perney; Walther Akemann; Thomas Knöpfel; Rolf H Joho
Journal:  Eur J Neurosci       Date:  2004-06       Impact factor: 3.386

9.  Cerebellar modules operate at different frequencies.

Authors:  Haibo Zhou; Zhanmin Lin; Kai Voges; Chiheng Ju; Zhenyu Gao; Laurens W J Bosman; Tom J H Ruigrok; Freek E Hoebeek; Chris I De Zeeuw; Martijn Schonewille
Journal:  Elife       Date:  2014-05-07       Impact factor: 8.140

10.  Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans.

Authors:  Joyce van de Leemput; Jayanth Chandran; Melanie A Knight; Lynne A Holtzclaw; Sonja Scholz; Mark R Cookson; Henry Houlden; Katrina Gwinn-Hardy; Hon-Chung Fung; Xian Lin; Dena Hernandez; Javier Simon-Sanchez; Nick W Wood; Paola Giunti; Ian Rafferty; John Hardy; Elsdon Storey; R J McKinlay Gardner; Susan M Forrest; Elizabeth M C Fisher; James T Russell; Huaibin Cai; Andrew B Singleton
Journal:  PLoS Genet       Date:  2007-05-16       Impact factor: 5.917

View more
  18 in total

1.  Nicotinamide Pathway-Dependent Sirt1 Activation Restores Calcium Homeostasis to Achieve Neuroprotection in Spinocerebellar Ataxia Type 7.

Authors:  Colleen A Stoyas; David D Bushart; Pawel M Switonski; Jacqueline M Ward; Akshay Alaghatta; Mi-Bo Tang; Chenchen Niu; Mandheer Wadhwa; Haoran Huang; Alex Savchenko; Karim Gariani; Fang Xie; Joseph R Delaney; Terry Gaasterland; Johan Auwerx; Vikram G Shakkottai; Albert R La Spada
Journal:  Neuron       Date:  2019-12-16       Impact factor: 17.173

Review 2.  Spinocerebellar ataxias: prospects and challenges for therapy development.

Authors:  Tetsuo Ashizawa; Gülin Öz; Henry L Paulson
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

3.  Genetic and clinical analyses of spinocerebellar ataxia type 8 in mainland China.

Authors:  Yao Zhou; Yanchun Yuan; Zhen Liu; Sheng Zeng; Zhao Chen; Lu Shen; Hong Jiang; Kun Xia; Beisha Tang; Junling Wang
Journal:  J Neurol       Date:  2019-08-30       Impact factor: 4.849

Review 4.  Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2.

Authors:  Polina A Egorova; Ilya B Bezprozvanny
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

5.  Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1.

Authors:  Ravi Chopra; David D Bushart; John P Cooper; Dhananjay Yellajoshyula; Logan M Morrison; Haoran Huang; Hillary P Handler; Luke J Man; Warunee Dansithong; Daniel R Scoles; Stefan M Pulst; Harry T Orr; Vikram G Shakkottai
Journal:  Hum Mol Genet       Date:  2020-11-25       Impact factor: 6.150

Review 6.  Pathogenic mechanisms underlying spinocerebellar ataxia type 1.

Authors:  Leon Tejwani; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2020-04-18       Impact factor: 9.261

Review 7.  Ion Channel Functions in Early Brain Development.

Authors:  Richard S Smith; Christopher A Walsh
Journal:  Trends Neurosci       Date:  2020-01-17       Impact factor: 13.837

8.  Clenbuterol-sensitive delayed outward potassium currents in a cell model of spinal and bulbar muscular atrophy.

Authors:  Vladimir A Martínez-Rojas; Daniele Arosio; Maria Pennuto; Carlo Musio
Journal:  Pflugers Arch       Date:  2021-05-22       Impact factor: 3.657

9.  A Chlorzoxazone-Baclofen Combination Improves Cerebellar Impairment in Spinocerebellar Ataxia Type 1.

Authors:  David D Bushart; Haoran Huang; Luke J Man; Logan M Morrison; Vikram G Shakkottai
Journal:  Mov Disord       Date:  2020-11-05       Impact factor: 10.338

10.  Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel-Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3.

Authors:  David D Bushart; Annie J Zalon; Hongjiu Zhang; Logan M Morrison; Yuanfang Guan; Henry L Paulson; Vikram G Shakkottai; Hayley S McLoughlin
Journal:  Cerebellum       Date:  2021-02       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.